Chirurgie - Fisteln

H. J. Buhr; A. J. Kroesen; E. F. Stange

doi:10.1055/s-2003-36667

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2003; 41(1): 43-49
DOI: 10.1055/s-2003-36667

Leitlinien der DGVS

Chirurgie - Fisteln

Surgery FistulasH. J. Buhr¹ , A. J. Kroesen¹ , E. F. Stange¹

¹Chirurgische Klinik I, Universitätsklinikum Benjamin Franklin, Berlin, und ¹Abteilung Innere Medizin I, Robert-Bosch-Krankenhaus, Stuttgart

Abstract

Full Text

References

Literatur

1 Hammer B. Current developments in the diagnosis and therapy of Crohn disease and ulcerative colitis. Schweiz Med Wochenschr. 1994; 124 452-460
2 Bauer J J, Harris M T, Grumbach N M. et al . Laparoscopic-assisted intestinal resection for Crohn’s disease. Which patients are good candidates?. J Clin Gastroenterol. 1996; 23 44-46
3 Gualdi G F, Volpe A, Polettini E. et al . Computerized tomography and magnetic resonance in the evaluation of patients with Crohn disease. Their role in the identification, assessment of extent and management of the disease. Clin Ter. 1994; 144 545-551
4 Pompili G G. et al . Computerized tomography in the diagnosis of Crohn disease. Radiol Med (Torino). 1994; 88 44-48
5 Raskin J B. Recent developments in gastrointestinal endoscopy. Postgrad Med. 1975; 57 85-92
6 Schunk K. et al . Follow-up of Crohn’s disease: can hydro-MRI replace fractionated gastrointestinal passage examination?. Röfo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1997; 166 389-396
7 McLeod R S. et al . Risk and significance of endoscopic/radiological evidence of recurrent Crohn’s disease. Gastroenterology. 1997; 113 1823-1827
8 Serizawa H. et al . Laparoscopically assisted ileocecal resection for Crohn’s disease associated with intestinal stenosis and ileovesical fistula. J Gastroenterol. 1996; 31 425-430
9 Goligher J C, de Dombal F T, Burton I. Crohn’s disease, with special reference to surgical management. Prog Surg. 1972; 10 1-23
10 Goligher J C. Inflammatory disease of the bowel: results of resection for Crohn’s disease. Dis Colon Rectum. 1976; 19 584-587
11 Herfarth C, Ewe K. Surgical treatment of Crohn’s disease. Chirurg. 1977; 48 569-576
12 Yamamoto T, Allan R N, Keighley M R. Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum. 2000; 43 1141-1145
13 Bernstein C N, Blanchard J F, Kliewer E. et al . Cancer risk in patients with inflammatory bowel disease. Cancer. 2001; 91 854-862
14 Greenstein A J. et al . Colorectal cancer in regional ileitis. Q J Med. 1987; 62 33-40
15 Muller-Decker K. et al . Cellular localization of cyclo-oxygenase isozymes in Crohn’s disease and colorectal cancer. Int J Colorectal Dis. 1999; 14 212-218
16 Nikias G. et al . Crohn’s disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Am J Gastroenterol. 1995; 90 216-219
17 Ribeiro M B. et al . Colorectal adenocarcinoma in Crohn’s disease. Ann Surg. 1996; 223 186-193
18 Sheil F O, Clark C G, Goligher J C. Adenocarcinoma associated with Crohn’s disease. Br J Surg. 1968; 55 53-58
19 Hirschfeld S, Clearfield H R. Pharmacologic therapy for inflammatory bowel disease. Am Fam Physician. 1995; 51 1971-1975
20 Kornbluth A, George J, Sachar D B. Immunosuppressive drugs in Crohn’s disease. Gastroenterologist. 1994; 2 239-246
21 Lamers C B, Griffioen G, van Hogezand R A. et al . Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease. Scand J Gastroenterol Suppl. 1999; 230 111-115
22 Rieger N, Stahl J, Wattchow D. Intractable Crohn’s colitis and perianal disease responding to cyclophosphamide and epirubicin. Dig Dis Sci. 1997; 42 2367-2369
23 Stange E F. The traditional immunosuppressors. Campieri et al Inflammatory bowel disease. A clinical case approach to pathophysiology, diagnosis and treatment Dordrecht; Kluwer Academic Publishers 2002: 201-205
24 Farkas S, Bero T, Kersak J. et al . Life-threatening gastrointestinal bleeding in Crohn disease. Orv Hetil. 1998; 139 2261-2262
25 Isbister W H. Colorectal operative experience in general surgical training. Int J Colorectal Dis. 1999; 14 69-72
26 Wolff B G. Crohn’s disease: the role of surgical treatment. Mayo Clin Proc. 1986; 61 292-295
27 Yamamoto T, Keighley M R. Long-term outcome of total colectomy and ileostomy for Crohn disease. Scand J Gastroenterol. 1999; 34 280-286
28 Buhr H J, Kallinowski F, Post S. et al .Recurrent Crohn - impact of surgical strategy. Lochs H, Schölmerich G IBD: Pathophysiology as basis of treatment Amsterdam; Academic Press 1993: 122-129
29 Buhr H J, Kroesen A J, Herfarth C. Surgical therapy of recurrent Crohn disease. Chirurg. 1995; 66 764-773
30 Sonnenberg A, Gavin M W. Timing of surgery for enterovesical fistula in Crohn’s disease: decision analysis using a time-dependent compartment model. Inflamm Bowel Dis. 2000; 6 280-285
31 Yamamoto T, Keighley M R. Enterovesical fistulas complicating Crohn’s disease: clinicopathological features and management. Int J Colorectal Dis. 2000; 15 211-215
32 Lee P Y. et al . Vaginal fistula following restorative proctocolectomy. Dis Colon Rectum. 1997; 40 752-759
33 Makowiec F, Jehle E C, Becker H D. et al . Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn’s disease. Br J Surg. 1995; 82 603-606
34 Ozuner G, Hull T L, Cartmill J. et al . Long-term analysis of the use of transanal rectal advancement flaps for complicated anorectal/vaginal fistulas. Dis Colon Rectum. 1996; 39 10-14
35 Scott N A, Nair A, Hughes L E. Anovaginal and rectovaginal fistula in patients with Crohn’s disease. Br J Surg. 1992; 79 1379-1380
36 Ozuner G, Fazio V W, Lavery I C. et al . Reoperative rates for Crohn’s disease following strictureplasty. Long-term analysis. Dis Colon Rectum. 1996; 39 1199-1203
37 Ewe K, Herfarth C, Malchow H. et al . Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion. 1989; 42 224-232
38 Fazio V W. et al . Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996; 224 563-571
39 Borley N R, Mortensen N J, Jewell D P. Preventing postoperative recurrence of Crohn’s disease. Br J Surg. 1997; 84 1493-1502
40 Hashemi M, Novell J R, Lewis A A. Side-to-side stapled anastomosis may delay recurrence in Crohn’s disease. Dis Colon Rectum. 1998; 41 1293-1296
41 Scott N A, Sue-Ling H M, Hughes L E. Anastomotic configuration does not affect recurrence of Crohn’s disease after ileocolonic resection. Int J Colorectal Dis. 1995; 10 67-69
42 Yamamoto T, Bain I M, Mylonakis E. et al . Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand J Gastroenterol. 1999; 34 708-713
43 Hildebrandt U, Ecker K W, Feifel G. Minimally invasive surgery and Crohn disease. Chirurg. 1998; 69 915-921
44 Schmidt C M. et al . Laparoscopic surgery for Crohn’s disease: reasons for conversion. Ann Surg. 2001; 233 733-739
45 Young-Fadok T M, HallLong K, McConnell E J. et al . Advantages of laparoscopic resection for ileocolic Crohn’s disease. Improved outcomes and reduced costs. Surg Endosc. 2001; 15 450-454
46 Prabhakar L P, Laramee C, Nelson H. et al . Avoiding a stoma: role for segmental or abdominal colectomy in Crohn’s colitis. Dis Colon Rectum. 1997; 40 71-78
47 Chevalier J M. et al . Colectomy and ileorectal anastomosis in patients with Crohn’s disease. Br J Surg. 1994; 81 1379-1381
48 Longo W E, Oakley J R, Lavery I C. et al . Outcome of ileorectal anastomosis for Crohn’s colitis. Dis Colon Rectum. 1992; 35 1066-1071
49 Panis Y. et al . Ileal pouch/anal anastomosis for Crohn’s disease. Lancet. 1996; 347 854-857
50 Kroesen A J, Buhr H J. Anorectal fistulas in Crohn disease. Zentralbl Chir. 1999; 124 (Suppl 2) 34-38
51 Beets-Tan R G. et al . Preoperative MR imaging of anal fistulas: Does it really help the surgeon?. Radiology. 2001; 218 75-84
52 Fazio V W, Tjandra J J. The management of perianal diseases. Adv Surg. 1996; 29 59-78
53 O’Donoghue D P, Hyland J M. Perianal Crohn’s disease (comment). Eur J Gastroenterol Hepatol. 1997; 9 235-236
54 Sangwan Y P, Schotz D J Jr, Murray J J. et al . Perianal Crohn’s disease. Results of local surgical treatment. Dis Colon Rectum. 1996; 39 529-535
55 Lichtenstein G R. Treatment of fistulizing Crohn’s disease. Gastroenterology. 2000; 119 1132-1147
56 Bernstein L H, Frank M S, Brandt L J. et al . Healing of perineal Crohn’s disease with metronidazole. Gastroenterology. 1980; 79 357-365
57 Brandt L, Bernstein L, Boley S. et al . Metronidazole therapy for perineal Crohn’s disease: a follow-up study. Gastroenterology. 1982; 83 383-387
58 Schneider M U, Laudage G, Guggenmoos-Holzman I. et al . Metronidazol in der Behandlung des Morbus Crohn. Dtsch Med Wochenschr. 1985; 110 1724-1730
59 Stahlberg D, Barany, Einarsson K. et al . Neurophysiologic studies of patients with Crohn’s disease on long-term treatment with metronidazole. Scand J Gastroenterol. 1991; 26 219-224
60 Turunen U, Farkkila M, Seppala K. Long-term treatment of perianal or fistulous Crohn’s disease with Ciprofloxacin (suppl 148). Scand J Gastroenterol. 1989; 24 144
61 Solomon M, McLeod R, O’Connor B. et al . Combination ciprofloxacin and metronidazole in severe perianal Crohn’s disease. Can J Gastroenterol. 1993; 571-573
62 Present D H, Korelitz B I, Wisch N. et al . Treatment of Crohn’s disease with 6-mercaptopurine: a long-term randomized double blind study. N Engl J Med. 1980; 302 981-987
63 Korelitz B I, Present D H. Favorable effect of 6-mercaptopurine on fistulae of Crohn’s disease. Dig Dis Sci. 1985; 30 58-64
64 O’Brien J J, Bayless T M, Bayless J A. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn’s disease. Gastroenterology. 1991; 101 39-46
65 Egan U, Sandborn W J, Tremaine W J. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn’s disease with intravenous cyclosporine. Am J Gastroenterol. 1998; 93 442-448
66 Hanauer S B, Smith M B. Rapid closure of Crohn’s disease fistulas with continous intravenous cyclosporin A. Am J Gastroenterol. 1993; 88 646-649
67 Present D H, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn’s disease. Dig Dis Sci. 1994; 29 374-380
68 Lowry P W, Weaver A L, Tremaine W J. et al . Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn’s disease perianal fistulae. Inflamm Bowel Dis. 1995; 5 239-245
69 Sandborn W J. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn’s disease. Am J Gastroenterol. 1997; 92 876-879
70 Fellermann K, Ludwig D, Stahl M. et al . Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (TK506). Am J Gastroenterol. 1998; 93 1860-1866
71 Muhadevan U, Marion J, Present D H. The place of methotrexate in the treatment of refractory Crohn’s disease (abstr). Gastroenterology. 1997; 112 A1031
72 Present D H, Rutgeerts P, Targan S. et al . Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med. 1999; 340 1398-1405
73 Fickert P, Hinterleitner T A, Wenzl H H. et al . Mycophenolate mofetil in patients with Crohn’s disease. Am J Gastroenterol. 1998; 93 2529-2532
74 Ehrenpreis E D, Kane S V, Cohen L B. et al . Thalidomine therapy for patients with refractory Crohn’s disease: an open-label trial. Gastroenterology. 1999; 117 1271-1277
75 Vasiliauskas E A, Kam L Y, Abreu-Martin M T. et al . an open-label pilot study of low-dose thalidomide in chronically acitve, steroid-dependent Crohn’s disease. Gastroenterology. 1999; 117 1278-1287
76 Lavy A, Weisz G, Adir Y. et al . Hyperbaric oxygen for perianal Crohn’s disease. J Clin Gastroenterol. 1994; 19 202-205
77 Colombel J F, Mathieu D, Bouault J M. et al . Hyperbaric oxygenation in severe perineal Crohn’s disease. Dis Colon Rectum. 1955; 38 609-614
78 Halverson A L. et al . Repair of recurrent rectovaginal fistulas. Surgery. 2001; 130 753-757